Home›Companies›Biotech & Pharma›Toggle Bio

Toggle Bio

Develops fluorescent antibodies for cell staining, imaging and analysis.

Updated Nov 9, 2026·Latest SEC filing Oct 6, 2026·Suggest an edit

About Toggle Bio

Toggle Bio is a private company based in Durham, North Carolina, incorporated in 2026 in Delaware. It has reported $200,000 raised in one offering on Form D since October 2026. Its chief executive is Craig LaBoda.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 2, 2026Oct 6, 2026$200,000fully sold14$14,286SAFEsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Toggle Bio's Form D filed Oct 6, 2026.

CL
Craig LaBoda
CEO and director
NP
Nicholas Pinkin
Executive officer and director
SB
Sean Burrows
Executive officer and director

Sources

  1. SECToggle Bio filing history